Guanylate Cyclase Activator YC-1 Enhances TRAIL-Induced Apoptosis in Human Epithelial Ovarian Carcinoma Cells via Activation of Apoptosis-Related Proteins

Current strategies to target p53 in cancer

(2010) Fang Chen et al.   BIOCHEMICAL PHARMACOLOGY

Cell death mechanisms: Cross-talk and role in disease

(2010) Boris Zhivotovsky et al.   EXPERIMENTAL CELL RESEARCH

A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB

(2009) Yao Dai et al.   BMC CANCER

TRAIL as a target in anti-cancer therapy

(2009) Gen Sheng Wu   CANCER LETTERS

Bax activation by Bim?

(2009) P E Czabotar et al.   CELL DEATH AND DIFFERENTIATION

Combined application of camptothecin and the guanylate cyclase activator YC-1: Impact on cell death and apoptosis-related proteins in ovarian carcinoma cell lines

(2009) Sun-Joo Lee et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Death receptors: Targets for cancer therapy

(2009) Zafar Mahmood et al.   EXPERIMENTAL CELL RESEARCH

Apoptotic mechanisms involved in neurodegenerative diseases: Experimental and therapeutic approaches

(2009) A. Camins et al.   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells

(2008) S. Huang et al.   CLINICAL CANCER RESEARCH

Cysteine Cathepsins Trigger Caspase-dependent Cell Death through Cleavage of Bid and Antiapoptotic Bcl-2 Homologues

(2008) Gabriela Droga-Mazovec et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226

(2007) Chun-Jen Chen et al.   BIOCHEMICAL PHARMACOLOGY